Our History

First isolation of adrenaline by Dr. Jokichi Takamine, the first president of Sankyo Shoten

Discovery of the first HMG-CoA reductase inhibitor by Sankyo - origin of the statin class

Daiichi discovers levofloxacin, the first third-generation quinolone

Launch of olmesartan, an angiotensin II receptor blocker

Launch of edoxaban, a non-vitamin K antagonist oral anticoagulant (NOAC) and direct factor Xa inhibitor

European Commission approval and first launch of bempedoic acid in Europe. Bempedoic acid and its fixed-dose combination with ezetimibe is approved for use in adults with primary hypercholesterolaemia or mixed dyslipidaemia in Europe**


**Bempedoic acid / the combination of bempedoic acid with ezetimibe was approved by the EMA in April 2020 with a first market launch in late 2020.

back to top

User login

Enter your username and password here in order to log in on the website

Dear User,
if you want to login you accept our cookie policy .